oral semaglutide and cardiovascular outcomes in high-risk type 2 diabetes of tirzepatide for patients with clinical practice Oral Semaglutide and Cardiovascular Outcomes

Significantly more accessible than IV

Oral Weight Loss Medications For patients who are needle-averse or have medical contraindications to GLP-1 injectables, Mochi providers may prescribe traditional oral weight loss medications, such as Contrave, Phentermine, or Metformin, based on individual medical appropriateness

The clinical data available for Ozempic does indicate that gastrointestinal side effects, such as nausea, are more prevalent at higher doses

These nutrients may help support healthy cholesterol levels and overall cardiovascular function when eaten in moderation as part of a balanced diet

(2022) Abdominal Visceral Adipose Tissue Over the Menopause Transition and Carotid Atherosclerosis: The SWAN Heart Study Li, Tanya, et al